Stem Cell Sciences plc
23 April 2008
For Immediate Release 23rd April 2008
Stem Cell Sciences plc
Holding(s) in Company
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached: Stem Cell Sciences plc
2. Reason for the notification (place an X inside the appropriate bracket/s)
An acquisition or disposal of voting rights: (X)
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: ( )
An event changing the breakdown of voting rights: ( )
Other (please specify) : ( )
.................
3. Full name of person(s) subject to the notification obligation:
AIM Realisation Fund Limited
4. Full name of shareholder(s) (if different from 3.) :
5. Date of the transaction (and date on which the threshold is crossed or
reached if different:14/04/08
6. Date on which issuer notified: 21/04/08
7. Threshold(s) that is/are crossed or reached: 4%
8. Notified details:
.................
A: Voting rights attached to shares
Class/type of shares if possible using the ISIN CODE: GB00B0BZYL27
Situation previous to the Triggering transaction
Number of shares: 2,674,239
Number of voting Rights: 2,674,239
Resulting situation after the triggering transaction
Class/type of shares if possible using the ISIN CODE: GB00B0BZYL27
Number of shares: 1,824,239
Number of voting rights: 1,824,239
Resulting situation after triggering transaction
Number of shares
Direct: 1,324,239
Indirect:
% of voting rights: 3.95%
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial instrument
Expiration Date
Exercise/Conversion Period/ Date
Number of voting rights that may be acquired if the instrument is exercised/
converted.
% of voting rights
Total (A+B)
Number of voting rights: 1,324,239
% of voting rights: 3.95%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
Proxy Voting:
10. Name of the proxy holder:
11. Number of voting rights proxy holder will cease to hold:
12. Date on which proxy holder will cease to hold voting rights:
13. Additional information:
Shareholding based on total voting rights of 33,516,149
.................
14. Contact name:
Giorgio Reggiani, Finance Director, Stem Cell Sciences Plc
15. Contact telephone number:
+44 (0)1223 499160
- Ends -
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.